Information for patients
A team from the University of Birmingham are leading an international research project to improve miscarriage care in low income countries. The study is recruiting 3400 women from Malawi, Tanzania, Uganda and Pakistan. The study is called the AIMS trial; Antibiotics In Miscarriage Surgery.
Miscarriage and miscarriage surgery are common and affects around 20 million women every year. The study will tell us if giving a single dose of antibiotics before surgery for miscarriage will reduce infection.
If it is found to be a successful strategy then the main beneficiaries will be women in low income countries, whom of which would be offered this treatment to reduce risk of infection after miscarriage surgery. This could reduce the occurrence of serious infection (sepsis) in these women, and reducing serious illness and death. It has the potential to also reduce serious long term complications such as ectopic pregnancy, subfertility and chronic pelvic pain.
It is a simple and inexpensive intervention, and if it is found to be effective it could be rapidly implemented. Miscarriage and miscarriage surgery are so common, that it places a major burden on health systems. Reducing miscarriage complications could not only improve outcomes for women globally, but it could also lead to more resources being available for other women's health services as this intervention would be targeted correctly.
Below you can find the patient information sheets in English, Chichewa, Swahili, Urdu, Sindhi, Ateso, Lugwere and Lumasaba.
Below is also some information for Health Care Professionals: